<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2024.123017</article-id><article-id pub-id-type="publisher-id">JBM-131851</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Advancements in Medication Rule for Pulmonary Nodules: A Review of Current Research Progress
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weilan</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shun</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Feng</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>First Clinical Medical College, Fujian University of Traditional Chinese Medicine, Fuzhou, China</addr-line></aff><aff id="aff1"><addr-line>Pneumology Department of The Second People’s Hospital Affiliated to Fujian University of Chinese Medicine, Fuzhou, China</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>03</month><year>2024</year></pub-date><volume>12</volume><issue>03</issue><fpage>193</fpage><lpage>203</lpage><history><date date-type="received"><day>20,</day>	<month>February</month>	<year>2024</year></date><date date-type="rev-recd"><day>17,</day>	<month>March</month>	<year>2024</year>	</date><date date-type="accepted"><day>20,</day>	<month>March</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  This paper reviewed the literature on medication rule of pulmonary nodules in recent years. It is found that contemporary doctors pay more attention to regulating Qi, clearing heat and detoxifying, eliminating phlegm, dissolving phlegm and dissipating masses. They use mild drugs, cold and warm treatments in parallel, combining the tastes of pungent, bitterness, and sweetness at the same time. The treatment focuses on the five viscera with emphasis on the lung meridian while also considering the spleen and stomach functions as well as soothing liver stagnation. This information aims to provide some reference for clinical treatment of pulmonary nodules.
 
</p></abstract><kwd-group><kwd>Pulmonary Nodules</kwd><kwd> Medication Rule</kwd><kwd> Review</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Pulmonary nodules are focal, circular, dense solid or subsolid pulmonary opacities with a diameter of ≤3 cm in the lung. They can occur as isolated lesions or multiple lesions and are typically not associated with atelectasis, hilar lymphadenopathy, or pleural effusion [<xref ref-type="bibr" rid="scirp.131851-ref1">1</xref>] . With the widespread use and increasing utilization of computerized tomography (CT), there has been a significant rise in the global detection rate of pulmonary nodules, which is approximately 20% [<xref ref-type="bibr" rid="scirp.131851-ref2">2</xref>] . There exist variations in the assessment and management of pulmonary nodules across different populations [<xref ref-type="bibr" rid="scirp.131851-ref3">3</xref>] . Typically, follow-up is the primary approach to managing detected nodules, leaving patients with a predicament of ‘easy detection but difficult treatment’. In traditional Chinese medicine, there is no direct equivalent term for pulmonary nodules; instead, doctors often refer to them as ‘lung accumulation’, ‘cough’, ‘asthmatic disease’, or other syndromic treatments [<xref ref-type="bibr" rid="scirp.131851-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref4">4</xref>] . The intervention of Traditional Chinese medicine in pulmonary nodules can effectively manage symptoms, enhance physical well-being, and induce local nodule control and shrinkage in certain patients. Additionally, as a complementary alternative therapy unsuitable for surgical procedures, it can also alleviate patient anxiety [<xref ref-type="bibr" rid="scirp.131851-ref4">4</xref>] . Currently, numerous researchers have investigated the rule of medication in the treatment of pulmonary nodules, with each physician exhibiting unique medication characteristics. However, no scholars have yet conducted comprehensive studies or explored their commonalities. Therefore, this review aims to synthesize recent literature on medication rule for pulmonary nodules, providing valuable clinical references for treatment strategies. The subsequent sections present a detailed analysis.</p></sec><sec id="s2"><title>2. Common Treatment</title><sec id="s2_1"><title>2.1. Pay Attention to Conditioning Qi Machine</title><sec id="s2_1_1"><title>2.1.1. Reinforcing Qi to Rectify Qi Deficiency</title><p>The results of numerous studies consistently indicate that the average age at which pulmonary nodules are typically detected is approximately 50 [<xref ref-type="bibr" rid="scirp.131851-ref5">5</xref>] - [<xref ref-type="bibr" rid="scirp.131851-ref11">11</xref>] , in line with previous research [<xref ref-type="bibr" rid="scirp.131851-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref13">13</xref>] . During this stage, individuals aged over 50 often experience physiological deficiencies and a weakened positive Qi, rendering them susceptible to external pathogens exploiting their vulnerabilities. Furthermore, internal pathogenic factors can easily arise due to the deficiency in positive Qi, leading to the accumulation of pathological substances within the lungs and subsequent formation of nodules. Contemporary doctors believe that the basic pathogenesis of pulmonary nodules involves deficiency-excess complex, and the main treatment should focus on supporting healthy Qi while also incorporating exorcism [<xref ref-type="bibr" rid="scirp.131851-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref4">4</xref>] . Some studies have indicated that Qi deficiency is the primary syndrome elements in pulmonary nodules [<xref ref-type="bibr" rid="scirp.131851-ref14">14</xref>] , so contemporary doctors use Qi-supplementing herbs for treating pulmonary nodules, such as astragalus, atractylodis macrocephalae rhizoma, codonopsis pilosula, dioscorea opposita, and pseudostellaria heterophylla [<xref ref-type="bibr" rid="scirp.131851-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref18">18</xref>] . The commonly used drug combinations include Radix pseudostellariae—Yam [<xref ref-type="bibr" rid="scirp.131851-ref19">19</xref>] , Radix Codonopsis—Tuckahoe [<xref ref-type="bibr" rid="scirp.131851-ref17">17</xref>] , Radix pseudostellariae—Tuckahoe [<xref ref-type="bibr" rid="scirp.131851-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref21">21</xref>] , Platycodonopsis platycodonopsis—Yam [<xref ref-type="bibr" rid="scirp.131851-ref9">9</xref>] , Radix Astragalus—Radix pseudostellariae [<xref ref-type="bibr" rid="scirp.131851-ref18">18</xref>] , Radix Astragalus—Radix pseudostellariae [<xref ref-type="bibr" rid="scirp.131851-ref14">14</xref>] , Radix Astragalus—Frangipani [<xref ref-type="bibr" rid="scirp.131851-ref22">22</xref>] and so on.</p></sec><sec id="s2_1_2"><title>2.1.2. Regulating Qi to Relieve Qi Stagnation</title><p>Pulmonary nodules are tangible and pathogenic, making them susceptible to obstructing the flow of Qi in the body’s energy system. Therefore, contemporary medical practitioners often focus on regulating Qi by supplementing it to alleviate stagnation in the Qi machinery. Professor Pang Lijian suggests that stagnation of Qi is a precursor to the formation of pulmonary nodules. This stagnant Qi hinders the transportation of body fluids, leading to accumulation and ultimately resulting in nodule formations. The combination of Codonopsis Radix and Bupleurum is commonly used to promote optimal circulation and relaxation of Qi for improved health [<xref ref-type="bibr" rid="scirp.131851-ref23">23</xref>] . Chief physician Zhou Dayong emphasized that in the early stage of pulmonary nodules, they are primarily formed due to the consolidation of Qi, phlegm, and dampness in the lungs. Therefore, it is essential to regulate Qi and eliminate phlegm while ensuring proper correction. This approach helps prevent the accumulation of blood stasis, toxins, and even malignant transformation over time [<xref ref-type="bibr" rid="scirp.131851-ref9">9</xref>] . Professor Lyu Xiaodong utilized costuscurcumae radix medicine for the treatment of pulmonary nodules, as the former plays a pivotal role in enhancing Qi circulation while the latter primarily focuses on promoting blood flow. The synergistic effect of these two medications enables direct regulation of the pathogenesis associated with pulmonary nodules by effectively balancing both Qi and blood [<xref ref-type="bibr" rid="scirp.131851-ref24">24</xref>] . Qi regulation is a common treatment for pulmonary nodules by Professor Shi Suofang, which includes soothing liver Qi using traditional Chinese medicines such as incense, curcumae radix, and Qingpi; conditioning lung Qi using traditional Chinese medicines like platycodon, almonds, and Perilla seeds; and tempering with traditional Chinese medicines like orange peel, fructus aurantii, and wood fragrance [<xref ref-type="bibr" rid="scirp.131851-ref25">25</xref>] . Chief physician Ma Zhanping attaches great importance to the pathogenesis of pulmonary nodules associated with “depression”. He often utilizes bitter almond and Perilla leaves, which can help regulate the Qi mechanism and resolve phlegm and blood stasis by promoting Qi circulation [<xref ref-type="bibr" rid="scirp.131851-ref26">26</xref>] .</p></sec></sec><sec id="s2_2"><title>2.2. Clearing Heat and Detoxifying, Resolving Phlegm and Clearing Knot</title><p>Pulmonary nodules are mainly diagnosed by imaging. They are nodules due to the accumulation of evil air in the lungs, such as benign and malignant tumors and inflammatory granulomatosis. Visible turbidity of phlegm obstructing the lungs is an important pathogenesis of pulmonary nodules [<xref ref-type="bibr" rid="scirp.131851-ref15">15</xref>] . Patients with pulmonary nodules tend to have a long disease course, and those with prolonged dampness and heat in the phlegm are common physical types associated with pulmonary nodules [<xref ref-type="bibr" rid="scirp.131851-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref27">27</xref>] , while accumulation of heat in the lungs is a common type of pulmonary nodules [<xref ref-type="bibr" rid="scirp.131851-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref17">17</xref>] . Therefore, treatment should focus on clearing heat, detoxifying phlegm, and dissipating it. Professor Luo Xiuli often uses Thunberg Fritillium and oyster to clear heat, resolve phlegm, soften hardness, and dissipate knots. This combination is the core drug pair for eliminating phlegm and dissolving knots [<xref ref-type="bibr" rid="scirp.131851-ref7">7</xref>] . Professor Xu Li pointed out that if spleen dampness does not move, internal obstruction of phlegm dampness occurs along with liver disorder and blocked Qi. This leads to non-coagulation of phlegm dampness and a higher susceptibility to pure glass nodules. Therefore, tangerine peel-pinellia is commonly used in patients with spleen-deficient phlegm dampness to eliminate phlegm and regulate Qi in the middle [<xref ref-type="bibr" rid="scirp.131851-ref28">28</xref>] . Professor Song Kang emphasized that heat toxicity plays a pivotal role as the primary pathogenic factor in the development of pulmonary nodules. Heat toxicity disrupts bodily fluids and depletes Qi, leading to the formation of phlegm, blockage of veins, and accumulation. In clinical practice, silkworm rigid-dilong medicine is commonly employed for detoxification purposes while simultaneously promoting blood circulation, eliminating phlegm, and resolving obstructions [<xref ref-type="bibr" rid="scirp.131851-ref29">29</xref>] .</p></sec></sec><sec id="s3"><title>3. Characteristics of Drug Usage</title><p>Extensive research has been conducted on the characteristics and preferences of contemporary physicians in the management of pulmonary nodules, revealing their inclination towards prescribing medications classified as cold, warm, flat, pungent, bitter or sweet [<xref ref-type="bibr" rid="scirp.131851-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.131851-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref34">34</xref>] .</p><sec id="s3_1"><title>3.1. Utilize both Cold and Warm, Gentle Medication</title><p>The majority of physicians employ cold, warm, and neutral pharmacotherapies for the management of pulmonary nodules, whereas only a minority utilize both cooling and heating medications. The pulmonary nodules primarily occur in the lungs, which are delicate and sensitive to temperature changes. Hence, a combination of cold, warm, and neutral drugs is prescribed to harmonize their effects for better therapeutic outcomes without causing harm or irritation to the lung tissues. This strategy aims at regulating Yin and Yang.</p></sec><sec id="s3_2"><title>3.2. Pungent Dispersing and Bitter Descending, Willing to Soft Lung</title><p>Professor Hu Guojun posits that the development of pulmonary nodules is attributed to the prolonged interaction between phlegm and Qi, coagulation of blood, as well as astringency [<xref ref-type="bibr" rid="scirp.131851-ref6">6</xref>] . Professor Lyu Xiaodong posits that the pathogenesis of this condition is primarily attributed to liver depression and Qi stagnation, which ultimately culminate in the development of phlegm and blood stasis over an extended duration. Moreover，a prolonged period of time will also result in deficiency of Yang Qi and the inability to resolve knots. Wang Hui, a nationally renowned TCM practitioner, believed that pulmonary sarcoidosis initially presented with no obvious clinical symptoms, which he referred to as “ju”. However, in the later stages of lesion progression, the symptoms became significant and diverse, a phenomenon he called “ji” [<xref ref-type="bibr" rid="scirp.131851-ref30">30</xref>] . Director Wang Sheng believed that the deficiency of healthy Qi was the basis for pulmonary nodules, and that spittoon and coagulation of Qi stagnation, blood stasis, and poison knot were its basic pathogenesis [<xref ref-type="bibr" rid="scirp.131851-ref32">32</xref>] . Professor Zhang Nianzhi pointed out that the pathological basis of pulmonary nodules is the imbalance of Qi and blood, and the main pathological factors are phlegm turbidity and blood stasis [<xref ref-type="bibr" rid="scirp.131851-ref17">17</xref>] . Professor Gong Hongwei believes that the basic pathogenesis of pulmonary nodules involves a deficiency in positive Qi and an excess of evil, as well as deficiencies in positive Qi, stagnation of Qi, interwoven phlegm and blood stasis leading to accumulation [<xref ref-type="bibr" rid="scirp.131851-ref8">8</xref>] . Professor Zheng Weiqin proposed the theory of “qi imbalance”, which suggests that prolonged imbalances in Qi can lead to abnormal activity in essence, blood, and body fluids, resulting in the formation of pathological substances such as phlegm, stasis, dampness, and toxicity. Over time, these substances accumulate and aggregate into nodules [<xref ref-type="bibr" rid="scirp.131851-ref18">18</xref>] . It can be seen that most doctors believe that the basic pathogenesis of pulmonary nodules is the deficiency of healthy Qi, which leads to the accumulation of sputum, dampness, blood stasis, and other evil Qi in the form of nodules. Pungent can open the lungs, bitterness can clear the lungs, Gan can moisturize the lungs. Pungent medicinals have a drying effect, while bitter medicinals promote the descent of Qi. This is also in line with the physiological characteristics of the lung, which prefers moistening and dislikes dryness. The herb pungent possesses the ability to enhance the movement of Qi and blood, alleviate Qi stagnation within the body, and prevent blood stasis in the lungs. Bitterness exhibits properties that can effectively eliminate dampness, strengthen lung function, counteract dryness caused by pathogenic factors, and when combined with sweetness, it can also mitigate potential harm from excessive bitter and warm attributes on pulmonary health. Consequently, a majority of medical practitioners employ pungent in conjunction with sweet and bitter herbs for treating pulmonary nodules.</p></sec></sec><sec id="s4"><title>4. Five Viscera Differentiation Focuses on the Middle and Upper Jiao</title><p>Numerous studies investigating the medication rule for pulmonary nodules have shown that practitioners primarily target the lung meridian while also regulating the spleen, stomach, and liver meridians, with consideration for the heart meridian as well [<xref ref-type="bibr" rid="scirp.131851-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref34">34</xref>] . Moreover, some practitioners also address the lower jiao in conjunction with the treatment of the upper and middle jiaos [<xref ref-type="bibr" rid="scirp.131851-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref35">35</xref>] .</p><sec id="s4_1"><title>4.1. Balance the Five Organs, with Emphasis on the Lung</title><p>Professor Yan Guizhen of our team has noted that pulmonary nodules fall within the Traditional Chinese Medicine categories of “phlegm nodules” or “cough” or “asthma” and so on [<xref ref-type="bibr" rid="scirp.131851-ref36">36</xref>] . Who suggesting that the etiology and pathogenesis of pulmonary nodules involve inherent deficiency of vital energy, external invasion by toxic and evil Qi, and the internal brewing of phlegm turbidity, stasis of blood, and damp full of toxics, all converging in the lungs. This condition is associated with dysfunction across multiple organs, with the primary disease location in the lungs, yet not confined solely to them [<xref ref-type="bibr" rid="scirp.131851-ref37">37</xref>] . Professor Yan’s understanding aligns with that of other medical practitioners: the formation of pulmonary nodules is related to imbalances in multiple organ functions, and while nodules primarily reside in the lungs, clinical treatment should aim for balace all five organs, often employing medications that enter the Taiyin lung meridian to directly address the root of the disease.</p></sec><sec id="s4_2"><title>4.2. Protect the Middle Jiao and Facilitating the Transformation and Function of the Spleen and Stomach</title><p>In addition to targeting the lung meridian, contemporary medical practitioners treating pulmonary nodules also choose medications that affect the spleen and stomach meridians. Modern diets, often greasy and surfeit flavour, typically result in a phlegm-damp constitution in clinical observations. Damage from dietary habits first affects the middle jiao; once the spleen and stomach are impaired, their transport and transformation functions fail, failing to metabolize fluids, leading to dampness coalescing into phlegm and accumulating in the lung lobes, hence presenting as lung accumulations. Therefore, practitioners frequently protect the spleen and stomach to facilitate their transport and transformation functions. Professor Shi Suofang believes that while pulmonary nodules are primarily located in the lungs and involve the liver and spleen, protecting the spleen and stomach is crucial for maintaining balance among the five organs. For patients with liver Qi stagnation and spleen deficiency or dual deficiency of lung and spleen, Liu Jun Zi Tang is often used as a base formula for treatment [<xref ref-type="bibr" rid="scirp.131851-ref25">25</xref>] . Professor Zhang Fuli holds that “Once the spleen and stomach are deficient, lung Qi fails first”, often employing methods to cultivating earth to control dampness, such as using ginger to warm and nourish the spleen and stomach, Fu Shen to soothe the mind and lighten the spleen, and Bai Zhu to invigorate the spleen and dry dampness to benefit the spleen and stomach [<xref ref-type="bibr" rid="scirp.131851-ref38">38</xref>] . Professor Zhu Jia advocates for cautious use of bitter and cold herbs to prevent damage to the spleen and stomach, opting for Si Jun Zi decoction or Shen Ling Bai Zhu San with modifications to reinforcing earth to generate metal, ensuring proper transformation and resolution of phlegm accumulations [<xref ref-type="bibr" rid="scirp.131851-ref15">15</xref>] .</p></sec><sec id="s4_3"><title>4.3. Focus on Emotional Well-Being and Regulate Liver Qi</title><p>The gender statistics for pulmonary nodules reveal that the detection rate in women surpasses that in men [<xref ref-type="bibr" rid="scirp.131851-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref38">38</xref>] . Considering the age of detection is often in the fifties, when many women in the period of perimenopause, emotional fluctuations markedly. Discovering pulmonary nodules during this time can lead to negative emotional responses, subsequently causing a series of psychosomatic changes. Clinically, it is common for patients with pulmonary nodules to experience anxiety and depression [<xref ref-type="bibr" rid="scirp.131851-ref39">39</xref>] . Since the primary approach to pulmonary nodules is “follow-up and monitoring” the fear of nodules progressing to malignancy or causing other adverse effects can impose a psychological burden greater than the nodules themselves. If this state persists, prolonged liver Qi stagnation can lead to complications, hence contemporary medical practitioners place significant emphasis on regulating the liver, employing strategies to disperse liver Qi and alleviate depression. Professor Gong Hongwei believes that pulmonary nodules are closely related to the liver and the spleen-stomach system. Beyond pulmonary symptoms like coughing and chest tightness, the psychological stress from concerns about nodules transforming into lung cancer can also manifest as symptoms of liver Qi stagnation, such as chest tightness and pain. Therefore, it is appropriate to select liver meridian drugs in prescription [<xref ref-type="bibr" rid="scirp.131851-ref8">8</xref>] . Professor Hu Kaiwen ingeniously applies the Five Elements Theory in treating pulmonary nodules, often using Yue Ju Wan to promote Qi movement and relieve depression, while also addressing stagnation in the lungs [<xref ref-type="bibr" rid="scirp.131851-ref34">34</xref>] . Professor Zhang Nianzhi adheres to the principle of “vent the wood constraint” frequently using bupleuri radix and aurantii fructus to disperse and soothe liver Qi, relieving the liver’s stagnation [<xref ref-type="bibr" rid="scirp.131851-ref17">17</xref>] . Professor Qu Niuni, in her clinical observations, found that some patients exhibit extreme anxiety about their pulmonary nodules, hence often uses bupleuri radix and aurantii fructus to soothe the liver and relieve depression, while also regulating the spleen and stomach Qi, restoring the pivotal ascending and descending functions [<xref ref-type="bibr" rid="scirp.131851-ref40">40</xref>] .</p></sec></sec><sec id="s5"><title>5. Summary</title><p>In this paper, we have summarized the literature on the medication rule of pulmonary nodules in recent years and further explored common treatment protocols for managing them. It is found that contemporary doctors pay more attention to regulating Qi, clearing heat and detoxifying, eliminating phlegm, dissolving phlegm and dissipating masses. They use mild drugs, cold and warm treatments in parallel, combining the tastes of pungent, bitterness, and sweetness at the same time. The treatment focuses on the five viscera with emphasis on the lung meridian while also considering the spleen and stomach functions as well as soothing liver stagnation. It is anticipated that this study will offer additional references for clinical treatment by Chinese medicine practitioners and provide essential data support for the development of novel drugs in the management of pulmonary nodules. While several researchers have employed cluster analysis to uncover patterns in pulmonary nodule administration and derived new prescriptions, only a few have validated their efficacy through clinical application [<xref ref-type="bibr" rid="scirp.131851-ref14">14</xref>] . Therefore, further clinical investigations of this nature are warranted. At the same time, network pharmacology and molecular docking studies can be used to further explore the mechanism of pulmonary nodule core prescription. However, this body of research has its limitations: 1) The number of prescriptions included in most literature is limited, often only amounting to a hundred and more, which may affect the accuracy of the results. 2) Few studies explore the relationship between different syndrome types of pulmonary nodules and medication, which is not conducive to differential diagnosis and treatment in clinical practice. 3) The safety profile of traditional Chinese medicine in the treatment of pulmonary nodules is relatively favorable; however, it is important to acknowledge the presence of potential side effects. Nevertheless, limited research has been conducted to evaluate the safety aspects associated with traditional Chinese medicine prescriptions for this particular condition. 4) The literature analyzed in this study indicates that the detection rate of pulmonary nodules in females is significantly higher than in males, yet other reports suggest a higher incidence rate of pulmonary nodules in males [<xref ref-type="bibr" rid="scirp.131851-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.131851-ref41">41</xref>] . This discrepancy could be due to women’s higher health consciousness and greater willingness to seek medical advice. Currently, there is a lack of authoritative epidemiological studies on pulmonary nodules, and whether there is a gender difference in the detection rate of pulmonary nodules still requires support from studies with larger sample sizes.</p></sec><sec id="s6"><title>Fund</title><p>Science and Technology Development Project of Chinese Rehabilitation Medical Association (Project No. KFKT-2022-024) “Study on the influence of Taijiquan on cardiopulmonary function and negative emotion in patients with pulmonary nodules”.</p><p>Fujian University of Traditional Chinese Medicine Major Scientific and Technological Innovation “Jie Bang Gua Shuai” special project (Project number: XJB2022002) “Construction of lung nodule risk stratified multidimensional markers and evaluation of exercise rehabilitation Program”.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Lin, W.L., Chen, S. and Lu, F. (2024) Advancements in Medication Rule for Pulmonary Nodules: A Review of Current Research Progress. Journal of Biosciences and Medicines, 12, 193-203. https://doi.org/10.4236/jbm.2024.123017</p></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.131851-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yang, G.W., Zhang, X.H., Zhang, H.R., et al. (2024) Expert Consensus on Whole-Process Management of Pulmonary Nodules with Integrated Traditional Chinese and Western Medicine. Chinese Journal of Experimental Traditional Medical Formulae, 30, 149-159.</mixed-citation></ref><ref id="scirp.131851-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bach, P.B., Mirkin, J.N., Sabichi, A.L., et al. (2012) Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review. JAMA: The Journal of the American Medical Association, 307, 2418-2429.  
https://doi.org/10.1001/jama.2012.5521</mixed-citation></ref><ref id="scirp.131851-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Steiling, K., Kathuria, H., Echieh, C.P., et al. (2023) Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine, 207, E31-E46.  
https://doi.org/10.1164/rccm.202212-2216ST</mixed-citation></ref><ref id="scirp.131851-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Yu, M.W., Zhang, H.R., Zhang, X.H., et al. (2024) Expert Consensus on Clinical Diseases Responding Specifically to Traditional Chinese Medicine: Pulmonary Nodules. Chinese Journal of Experimental Traditional Medical Formulae, 30, 238-245.</mixed-citation></ref><ref id="scirp.131851-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Q.M. (2023) Investigation on Traditional Chinese Medicine Constitution of Pulmonary Nodules and Study on Clinical Medication Rule. Liaoning University of Traditional Chinese Medicine, Shenyang.</mixed-citation></ref><ref id="scirp.131851-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Han, L.L. (2020) Data Mining Research on the Differentiation and Treatment of Lung Nodules by Hu Guojun’s Famous Traditional Chinese Medicine. Anhui University of Traditional Chinese Medicine, Hefei.</mixed-citation></ref><ref id="scirp.131851-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gao, N. and Qin, D.M. (2023) Analysis of Medication Rules of Professor Luo Xiuliin Treating Pulmonary Nodules Based on Data Mining. Research of Integrated Traditional Chinese and Western Medicine, 15, 289-294.</mixed-citation></ref><ref id="scirp.131851-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Tian, H. (2022) Study on Drug Use of Professor Gong Hongwei in the Treatment of Pulmonary Nodules Based on Data Mining. Hubei University of Traditional Chinese Medicine, Wuhan.</mixed-citation></ref><ref id="scirp.131851-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Quan, X. (2023) Study on Drug Use of Zhou Dayong in the Treatment of Pulmonary Nodules Based on Data Mining. Anhui University of Traditional Chinese Medicine, Hefei.</mixed-citation></ref><ref id="scirp.131851-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cao, M.J. (2023) Summarize the Rule of Chinese Medicine in Treating Pulmonary Nodules Based on Data Mining. Changchun University of Chinese Medicine, Changchun.</mixed-citation></ref><ref id="scirp.131851-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y.P., Ma, L., Zhang, C.X., et al. (2023) Zhang Changxi’s Drug Use in the Treatment of Pulmonary Sarcoidosis. Chinese Folk Therapy, 31, 45-48.</mixed-citation></ref><ref id="scirp.131851-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Wang, W.H., Cao, Y., Wang, X.C., et al. (2022) Clinical Characteristics and Influencing Factors of Pulmonary Nodules Detected in Early Screening of Lung Cancer in Zhengzhou. Chinese Journal of Cancer Prevention and Treatment, 29, 468-474.</mixed-citation></ref><ref id="scirp.131851-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Xu, H.J., Zhuang, W.T., Wang, Q., et al. (2023) Distribution Pattern of Respiratory Symptoms and the Relevant Risk Factors in Patients with Pulmonary Nodules: A Cross-Sectional Study. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 30, 1175-1180.</mixed-citation></ref><ref id="scirp.131851-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Cai, R.J. (2023) Professor Lin Hongsheng’s Experience in Identifying and Treating Pulmonary Nodules. China Academy of Chinese Medical Sciences, Beijng.</mixed-citation></ref><ref id="scirp.131851-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Gao, M.J. (2022) Professor Zhu Jia’s Experience in Treating Pulmonary Nodules Based on Data Mining. Nanjing University of Traditional Chinese Medicine, Nanjing.</mixed-citation></ref><ref id="scirp.131851-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Dong, J., Peng, X.Y., Fu, X., et al. (2022) Medication Regularity and Mechanisms of Traditional Chinese Medicine in Treatment Pulmonary Nodule: A Study Based on Data Mining and Network Pharmacology. Chinese Traditional and Herbal Drugs, 53, 6544-6557.</mixed-citation></ref><ref id="scirp.131851-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Rui, H.L. (2023) Study on Drug Use and Mechanism of Professor Zhang Nianzhi in Treatingpulmonary Nodules Based on Data Mining Technology and Network Pharmacology. Anhui University of Traditional Chinese Medicine, Hefei.</mixed-citation></ref><ref id="scirp.131851-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Liu, P.Y., Xu, X.Y., Liu, W.Q., et al. (2023) Medication Rule of Zheng Weiqin in Treatment of Pulmonary Nodules: A Study Based on Data Mining. Hunan Journal of Traditional Chinese Medicine, 39, 34-38.</mixed-citation></ref><ref id="scirp.131851-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, H.Y., Cao, J., Chen, Y., et al. (2020) Analysis of the Rule of Lung Nodule Treatment by Chief Physician Luo Ling Based on Association Rules. Journal of Practical Traditional Chinese Internal Medicine, 34, 7-11.</mixed-citation></ref><ref id="scirp.131851-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Li, R. (2023) Study on Clinical Drug Use Rule of Traditional Chinese Medicine in Treating Pulmonary Nodules Based on Data Mining. Yunnan University of Traditional Chinese Medicine, Kunming.</mixed-citation></ref><ref id="scirp.131851-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Huang, J.H., Zeng, Z.Y., Wu, G.P., et al. (2022) Based on Traditional Chinese Medicine (TCM) Inheritance Computing Platform, the Rule of TCM Medicine in Treating Pulmonary Nodules Was Studied. Chinese Journal of Geriatric Care, 20, 47-51.</mixed-citation></ref><ref id="scirp.131851-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Li, D.X., Wang, H.H., Luo, X., et al. (2023) Analysis of Drug Use in the Treatment of Pulmonary Nodules by Professor Zhang Shunian. World Chinese Medicine, 18, 1-5.</mixed-citation></ref><ref id="scirp.131851-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, X. (2023) Exploring the Emotional Characteristics and Medication Rules of Female Pulmonary Nodule Patients Based on “Women’s Liver Is Congenital”. Liaoning University of Traditional Chinese Medicine, Kunming.</mixed-citation></ref><ref id="scirp.131851-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Huang, H. (2023) Study on Professor Lv Xiaodong’s Experience in Treating Lung Nodules and Thyroid Nodules Based on “Common Treatment of Different Diseases”. Liaoning University of Traditional Chinese Medicine, Kunming.</mixed-citation></ref><ref id="scirp.131851-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Xue, Y.F. (2021) Study on the Clinical Experience and Medication Rule of Professor Shi Suofang in the Treatment of Pulmonary Nodules Based on Data Mining. Nanjing University of Chinese Medicine, Nanjing.</mixed-citation></ref><ref id="scirp.131851-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, X.W., Huang, G., Wang, Z.M., et al. (2021) Study on Rules of Prescriptions and Medicines for the Treatment of Pulmonary Nodules by Traditional Chinese Medicine Based on Data Mining. Evaluation and Analysis of Drug-Use in Hospitals of China, 21, 981-986.</mixed-citation></ref><ref id="scirp.131851-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Hu, J.R., Zhang, X.M., Li, M.Q., et al. (2023) Investigation about Constitution of Traditional Chinese Medicine of 340 Pulmonary Nodules Patients. China Journal of Traditional Chinese Medicine and Pharmacy, 38, 4996-4999.</mixed-citation></ref><ref id="scirp.131851-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Wu, L.J., Lu, J.W., Feng, X., et al. (2023) A Study on Medical Records of Treating Subsolid Pulmonary Nodule by Professor Xu Li Based on Data Mining. Clinical Journal of Chinese Medicine, 15, 93-98.</mixed-citation></ref><ref id="scirp.131851-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Zhou, L.M., Wan, S.H. and Song, K. (2023) Based on Data Mining, Songkang Drug Administration in the Treatment of Pulmonary Nodules Was Explored. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 33, 367-371.</mixed-citation></ref><ref id="scirp.131851-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Luo, X.P., Wang, F., Lu, P.P., et al. (2020) An Analysis of Administration Rule of Wang Huireng in Treating Pulmonary Nodules Based on the Data Mining. New Chinese Medicine, 52, 7-10.</mixed-citation></ref><ref id="scirp.131851-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y., Sheng, G.C. and Zhang, Z.J. (2023) An Analysis of Medication Rule of Traditional Chinese Medicine in Treating Pulmonary Nodules Based on Data Mining. China Modern Doctor, 61, 60-64.</mixed-citation></ref><ref id="scirp.131851-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Shi, X.Q. (2023) Research on TCM Syndrome Differentiation and Treatment of Pulmonary Nodules by Director Wang Sheng Based on Data Mining Technology. Anhui Hospital of Traditional Chinese Medicine University, Hefei.</mixed-citation></ref><ref id="scirp.131851-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Hu, Z.W. (2023) Discussion on the Idea of Professor Xue Hanrong Using Yanghe Decoction to Treat Patients with Pulmonary Nodules (Type of Yang Deficiency and Phlegm Condensation). Jiangxi University of Traditional Chinese Medicine, Nanchang.</mixed-citation></ref><ref id="scirp.131851-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Dai, Y.W., Li, Y. and Hu, K.W. (2022) Medication Rules of Professor Hu Kaiwen in Treatment of Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Support System. World Journal of Integrated Traditional and Western Medicine, 17, 1934-1938.</mixed-citation></ref><ref id="scirp.131851-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Z.B. (2022) Study on the Rule of Traditional Chinese Medicine in the Treatment of Pulmonary Nodules Based on Data Mining. Liaoning University of Traditional Chinese Medicine, Shenyang.</mixed-citation></ref><ref id="scirp.131851-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Lu, F. and Yan, G.Z. (2021) Yan Guizhen’s Experience Collection of Pulmonary Rehabilitation. Fujian Science and Technology Press, Fuzhou.</mixed-citation></ref><ref id="scirp.131851-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Chen, G.J., Wang, C.N. and Yan, G.Z. (2023) Professor Yan Guizhen’s Experience in Treating Pulmonary Nodules with Fuzhengquxie. Chinese Manipulation and Rehabilitation Medicine, 14, 18-20.</mixed-citation></ref><ref id="scirp.131851-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Feng, R. (2023) Study on Medication Regularity of Professor Zhang Fuli in the Treatment of Benign Pulmonary Nodules Based on Data Mining. Heilongjiang University of Chinese Medicine, Harbin.</mixed-citation></ref><ref id="scirp.131851-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Wu, J.H., Zhuang, W.T., Xu, H.J., et al. (2023) Anxiety and Depression in the Patients with Pulmonary Nodules and Its Related Influencing Factors: A Cross-Sectional Study. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 30, 357-363.</mixed-citation></ref><ref id="scirp.131851-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Li, T. (2023) Study on Drug Administration and Network Pharmacology of Professor Qu Nini in Treatment of Subcentimeter Ground Glass Density Pulmonary Nodules. Liaoning University of Traditional Chinese Medicine, Shenyang.</mixed-citation></ref><ref id="scirp.131851-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, J.L., Qin, Q.R., Liu, M.Y., et al. (2022) Study on Pulmonary Nodules Outcome and Risk Factors of Lung Cancer Screening Population in Ma’anshan. Modern Preventive Medicine, 49, 2517-2522.</mixed-citation></ref></ref-list></back></article>